在用伊匹单抗治疗期间发生的风湿性多肌痛。 - Suppr

Suppr

超能文献

Polymyalgia rheumatica occurring during treatment with ipilimumab.

作者信息

Maniu Christa, Kobe Carsten, Schlaak Max, Mauch Cornelia, Eming Sabine A

机构信息

Department of Dermatology.

Department of Nuclear Medicine, University of Cologne, 50937 Cologne, Germany.

出版信息

Eur J Dermatol. 2016 Oct 1;26(5):513-514. doi: 10.1684/ejd.2016.2837.

DOI:10.1684/ejd.2016.2837

PMID:27349150

Abstract

摘要

相似文献

Polymyalgia rheumatica occurring during treatment with ipilimumab.

Eur J Dermatol. 2016 Oct 1;26(5):513-514. doi: 10.1684/ejd.2016.2837.

Pembrolizumab-induced polymyalgia rheumatica in two patients with metastatic melanoma.

Joint Bone Spine. 2017 Mar;84(2):233-234. doi: 10.1016/j.jbspin.2016.01.007. Epub 2016 Apr 25.

Drug-associated polymyalgia rheumatica/giant cell arteritis occurring in two patients after treatment with ipilimumab, an antagonist of ctla-4.

Arthritis Rheumatol. 2014 Mar;66(3):768-9. doi: 10.1002/art.38282.

Polymyalgia rheumatica in a melanoma patient due to nivolumab treatment.

J Cancer Res Clin Oncol. 2017 Jul;143(7):1357-1358. doi: 10.1007/s00432-017-2410-x. Epub 2017 May 17.

Subclinical aortitis after starting nivolumab in a patient with metastatic melanoma. A case of drug-associated aortitis?

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):171. Epub 2018 May 18.

Nursing management of patients with metastatic melanoma receiving ipilimumab.

Oncol Nurs Forum. 2013 May 1;40(3):215-8. doi: 10.1188/13.ONF.215-218.

Ipilimumab (Yervoy) and inoperable or metastatic melanoma. More evaluation needed, in both first- and second-line use.

Prescrire Int. 2015 Apr;24(159):96.

Ipilimumab-induced hypophysitis: early Australian experience.

Med J Aust. 2014 Aug 18;201(4):198-9. doi: 10.5694/mja14.00803.

Enterocolitis in a patient being treated with ipilimumab for metastatic melanoma.

Gastroenterology. 2012 Aug;143(2):298, 504, 505. doi: 10.1053/j.gastro.2012.01.042. Epub 2012 Jun 16.

Long-lasting responses under treatment with ipilimumab: an argument against maintenance therapy?

Dermatology. 2015;230(1):8-10. doi: 10.1159/000365078. Epub 2014 Dec 13.

引用本文的文献

Imaging Findings in Patients with Immune Checkpoint Inhibitor-Induced Arthritis.

Diagnostics (Basel). 2022 Aug 13;12(8):1961. doi: 10.3390/diagnostics12081961.

Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published Literature.

Medicines (Basel). 2020 Nov 3;7(11):68. doi: 10.3390/medicines7110068.

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.

Ann Rheum Dis. 2021 Jan;80(1):36-48. doi: 10.1136/annrheumdis-2020-217139. Epub 2020 Apr 23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Polymyalgia rheumatica occurring during treatment with ipilimumab.

Eur J Dermatol. 2016 Oct 1;26(5):513-514. doi: 10.1684/ejd.2016.2837.

Pembrolizumab-induced polymyalgia rheumatica in two patients with metastatic melanoma.

Joint Bone Spine. 2017 Mar;84(2):233-234. doi: 10.1016/j.jbspin.2016.01.007. Epub 2016 Apr 25.

Drug-associated polymyalgia rheumatica/giant cell arteritis occurring in two patients after treatment with ipilimumab, an antagonist of ctla-4.

Arthritis Rheumatol. 2014 Mar;66(3):768-9. doi: 10.1002/art.38282.

Polymyalgia rheumatica in a melanoma patient due to nivolumab treatment.

J Cancer Res Clin Oncol. 2017 Jul;143(7):1357-1358. doi: 10.1007/s00432-017-2410-x. Epub 2017 May 17.

Subclinical aortitis after starting nivolumab in a patient with metastatic melanoma. A case of drug-associated aortitis?

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):171. Epub 2018 May 18.

Nursing management of patients with metastatic melanoma receiving ipilimumab.

Oncol Nurs Forum. 2013 May 1;40(3):215-8. doi: 10.1188/13.ONF.215-218.

Ipilimumab (Yervoy) and inoperable or metastatic melanoma. More evaluation needed, in both first- and second-line use.

Prescrire Int. 2015 Apr;24(159):96.

Ipilimumab-induced hypophysitis: early Australian experience.

Med J Aust. 2014 Aug 18;201(4):198-9. doi: 10.5694/mja14.00803.

Enterocolitis in a patient being treated with ipilimumab for metastatic melanoma.

Gastroenterology. 2012 Aug;143(2):298, 504, 505. doi: 10.1053/j.gastro.2012.01.042. Epub 2012 Jun 16.

Long-lasting responses under treatment with ipilimumab: an argument against maintenance therapy?

Dermatology. 2015;230(1):8-10. doi: 10.1159/000365078. Epub 2014 Dec 13.

引用本文的文献

Imaging Findings in Patients with Immune Checkpoint Inhibitor-Induced Arthritis.

Diagnostics (Basel). 2022 Aug 13;12(8):1961. doi: 10.3390/diagnostics12081961.

Medicines (Basel). 2020 Nov 3;7(11):68. doi: 10.3390/medicines7110068.

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.

Ann Rheum Dis. 2021 Jan;80(1):36-48. doi: 10.1136/annrheumdis-2020-217139. Epub 2020 Apr 23.

Polymyalgia rheumatica occurring during treatment with ipilimumab.

作者信息

Maniu Christa, Kobe Carsten, Schlaak Max, Mauch Cornelia, Eming Sabine A

机构信息

Department of Dermatology.

Department of Nuclear Medicine, University of Cologne, 50937 Cologne, Germany.

出版信息

Eur J Dermatol. 2016 Oct 1;26(5):513-514. doi: 10.1684/ejd.2016.2837.

DOI:10.1684/ejd.2016.2837

PMID:27349150

Abstract

摘要